Sterile Urine Notion Shown to Be a Myth
By HospiMedica International staff writers Posted on 13 Apr 2015 |
A new study has discredited the common belief that normal human urine is sterile.
Researchers at Loyola University (Chicago, IL, USA) evaluated urine specimens from 90 healthy women, collected directly from the bladder through aspiration or a catheter to avoid skin contamination. The specimens were analyzed using an expanded quantitative urine culture (EQUC) technique that can identify bacteria not detectable by standard urine culture techniques that are used to diagnose urinary tract syndromes. The study also used 16S rDNA sequencing to classify bacterial DNA.
The researchers found that bladder bacteria in healthy women differ from the bladder bacteria in those affected by an overactive bladder (OAB), and contribute to symptoms of urinary incontinence. The presence of bacteria could also correlate with other common lower urinary tract disorders, such as urinary tract infections and painful bladder syndromes. The results also revealed that some bacteria are more common in women with urgency urinary incontinence than in healthy women. The study was published in the March 2015 issue of European Urology.
“Clinicians previously equated the presence of bacteria in urine to infections. The discovery of bacteria in the urine of healthy females provides an opportunity to advance our understanding of bladder health and disease,” said lead author Prof. Alan Wolfe, PhD, of the department of microbiology and immunology. “Physicians and researchers must reassess their assumptions surrounding the cause of lower urinary tract disorders and consider new approaches to prevent and treat these debilitating health issues.”
It is commonly believed that urine is sterile until it reaches the urethra, where epithelial cells lining the urethra are colonized by facultatively anaerobic Gram negative rods and cocci. Using EQUC, the researchers identified 35 different genera and 85 different species, with the most prevalent genera isolated being Lactobacillus (15%), followed by Corynebacterium (14.2%), Streptococcus (11.9%), Actinomyces (6.9%), and Staphylococcus (6.9%). Other genera isolated include Aerococcus, Gardnerella, Bifidobacterium, and Actinobaculum.
Related Links:
Loyola University
Researchers at Loyola University (Chicago, IL, USA) evaluated urine specimens from 90 healthy women, collected directly from the bladder through aspiration or a catheter to avoid skin contamination. The specimens were analyzed using an expanded quantitative urine culture (EQUC) technique that can identify bacteria not detectable by standard urine culture techniques that are used to diagnose urinary tract syndromes. The study also used 16S rDNA sequencing to classify bacterial DNA.
The researchers found that bladder bacteria in healthy women differ from the bladder bacteria in those affected by an overactive bladder (OAB), and contribute to symptoms of urinary incontinence. The presence of bacteria could also correlate with other common lower urinary tract disorders, such as urinary tract infections and painful bladder syndromes. The results also revealed that some bacteria are more common in women with urgency urinary incontinence than in healthy women. The study was published in the March 2015 issue of European Urology.
“Clinicians previously equated the presence of bacteria in urine to infections. The discovery of bacteria in the urine of healthy females provides an opportunity to advance our understanding of bladder health and disease,” said lead author Prof. Alan Wolfe, PhD, of the department of microbiology and immunology. “Physicians and researchers must reassess their assumptions surrounding the cause of lower urinary tract disorders and consider new approaches to prevent and treat these debilitating health issues.”
It is commonly believed that urine is sterile until it reaches the urethra, where epithelial cells lining the urethra are colonized by facultatively anaerobic Gram negative rods and cocci. Using EQUC, the researchers identified 35 different genera and 85 different species, with the most prevalent genera isolated being Lactobacillus (15%), followed by Corynebacterium (14.2%), Streptococcus (11.9%), Actinomyces (6.9%), and Staphylococcus (6.9%). Other genera isolated include Aerococcus, Gardnerella, Bifidobacterium, and Actinobaculum.
Related Links:
Loyola University
Latest Critical Care News
- New Prostate Screening Device Could Replace Traditional Examination Method
- Adaptive Spine Board to Revolutionize ER Transport
- Mapping Communication Between Internal Organs to Enable Earlier Illness Diagnosis
- Intelligent Wound Dressing Reduces Inflammation and Promotes Healing
- Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension
- New Understanding of Barrett’s Esophagus Formation to Enable Earlier Intervention and Diagnosis
- 3D Printed Functional Human Islets Could Transform Type 1 Diabetes Treatment
- AI Model Predicts ICU mortality in Heart Failure Patients
- Smart Capsule Offers Real-Time Profiling Across GI Tract
- Ultra-Thin Implant Helps Patients with Spinal Cord Injury Recover Lost Functions
- Portable Cell Therapy Device to Enable Rapid On-Demand Modification of RBCs at POC
- Monitoring Airborne Fungal Spores Could Help Predict COVID-19 & Flu Surges
- New System Measures Blood Sodium Without Needles
- Sleep Data from Wearable Device May Help Predict Preterm Birth
- AI Tool Interprets Echocardiograms in Minutes
- Electrochemical Catheter Hub Prevents Bloodstream Infections
Channels
Surgical Techniques
view channel
LED-Based Imaging System Could Transform Cancer Detection in Endoscopy
Gastrointestinal cancers remain one of the most common and challenging forms of cancer to diagnose accurately. Despite the widespread use of endoscopy for screening and diagnosis, the procedure still misses... Read more
New Surgical Microscope Offers Precise 3D Imaging Using 48 Tiny Cameras
Surgeons have long relied on stereoscopic microscopes to gain depth perception during delicate procedures, but this method has limitations. While these microscopes provide a sense of three-dimensionality,... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more